Complimentary U.S. shipping on orders over $250 American-manufactured Independently verified Documentation on request
01 Catalog GLP-2 (5MG) incretin analog research peptide vial — BioFusion Aminos
Catalog

Tirz GLP-2 (5MG)

GLP-2 (5MG) lyophilized peptide for laboratory research. HPLC-verified ≥99% purity, batch-specific COA, American-manufactured. Ships 24h.

$135.00


Proceed to Checkout

Research Use Only. Not for human or veterinary use.

American-manufactured Ships 24-48h Research Use Only
About the Standard

Documented reference chemistry.

GLP-2 — the dual-incretin (GLP-1 + GIP receptor) research analog from the tirzepatide class — supplied by BioFusion as a vacuum-sealed lyophilized vial of 5mg for dual-receptor incretin-biology research.

Research context

GLP-2 in the BioFusion catalog refers to the tirzepatide-class dual-incretin research analog (GLP-1R + GIPR co-agonist), distinct from the natural intestinotropic GLP-2 peptide. The dual-incretin class has been the fastest-growing reference-peptide research segment of 2024-2025, displacing single-receptor GLP-1 analogs in many comparative-chemistry panels. The GLP-1 chemistry primer covers the structural basis of single- vs dual- vs triple-incretin classes.

Synthesis & documentation

Produced by solid-phase peptide synthesis using Fmoc protecting-group strategy in a U.S.-based ISO 9001:2008 facility. Each lot is verified for identity (LC-MS), purity (reverse-phase HPLC-UV ≥99.0%), moisture (Karl Fischer), and counter-ion (ion chromatography). The signed Certificate of Analysis ships with every order. Compare directly with our GLP-1 single-incretin reference and GLP-3 triple-incretin reference.

Storage & handling

Lyophilized GLP-2 is stable at −20 °C for the printed shelf life. After reconstitution, the standard 14-day-at-2-8 °C reference window applies; avoid freeze-thaw cycling. The BioFusion reconstitution calculator handles working-concentration math for any intended protocol.

Why BioFusion

The dual-incretin segment has attracted significant counterfeiting since the tirzepatide patent landscape opened in research-supply markets. BioFusion’s GLP-2 reference is verified by LC-MS for the correct molecular weight (no truncation, no incorrect coupling), with HPLC-purity ≥99.0% confirmed on every lot. Batch transparency ledger publishes synthesis-date and purity per release. Bulk discounts at three+ vials; members save 25% on every order plus complimentary U.S. shipping for 365 days.

For research and laboratory use only. This product is not a drug, food, or cosmetic, and is not intended for diagnostic, therapeutic, or in vivo human use.

From the Same Class

Related reference standards.

View the catalog →